CompletedEUCTR 2018-002782-19
CARIPRAZINE for depression
This study is completed in the United Kingdom, in Germany, in Hungary, .... It is testing CARIPRAZINE for depression.
In United KingdomDepressionOther
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
OngoingEUCTR 2017-002227-13
Pimavanserin for Schizophrenia
This study is ongoing in France, in the United Kingdom, in Czechia, .... It is testing pimavanserin for Schizophrenia.
In United KingdomSchizophreniaOther
CompletedEUCTR 2020-000341-14
Seltorexant 20 mg for Depression
This study is completed in the United Kingdom, in Belgium, in Czechia, .... It is testing Seltorexant 20 mg for Depression.
In United KingdomDepressionOther
TerminatedISRCTN04540006
A feasibility study to analyse the psychological benefits of green exercise (GE) in comparison to cognitive behavioural therapy (CBT) with people with mild to moderate depression
This study was terminated in the United Kingdom. It focuses on depression.
In United KingdomDepressionOtherOver 18 Years
CompletedNCT00700427
A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
This study is completed. It focuses on ADHD and currently lists study information in Austria, Belgium, Finland, France, Germany, Italy, the Netherlands, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.
In United KingdomADHDOtherFrom 18 Years to 50 Years
OngoingEUCTR 2017-001739-38
Safety study of Multiple Oral Doses of TAK-831 in Schizophrenia
This study is ongoing in the United Kingdom and . It is testing Multiple Oral Doses of TAK-831 for Schizophrenia.
In United KingdomSchizophreniaOther
CompletedEUCTR 2018-003825-27
Safety study of Safety and Efficacy of BIIB104 in schizophrenia
This study is completed in the United Kingdom, in Germany, and . It is testing Safety and Efficacy of BIIB104 for schizophrenia.
In United KingdomSchizophreniaOther
CompletedNCT04951076
Study of BNC210 Tablet Formulation in Adults With PTSD (PTSD)
This study is completed. It focuses on PTSD and currently lists study information in the United States and the United Kingdom.
In United KingdomPTSDDrugA study involving a medication or substance.From 18 Years to 75 Years
Active Not RecruitingNCT06809595
Study of MM120 for Generalized Anxiety Disorder (Panorama)
This study is active but not recruiting in the United States, in France, in the United Kingdom, .... It focuses on anxiety.
In United KingdomAnxietyOtherFrom 18 Years to 74 Years
OngoingEUCTR 2018-000821-29
2-part Study Composed of a 1-Year Active-comparator, Dose-optimization Evaluation followed by a 1-Year Open-lab...
This study is ongoing in the United Kingdom, in Belgium, in Germany, .... It focuses on ADHD.
In United KingdomADHDOther
OngoingEUCTR 2016-004973-42
Efficacy, safety, and tolerability of orally administered BI 409306 during a 52-week treatment period for Schizophrenia
This study is ongoing in the United Kingdom and . It is testing efficacy, safety, and tolerability of orally administered BI 409306 during a 52-week treatment period for Schizophrenia.
In United KingdomSchizophreniaOther
OngoingEUCTR 2018-002740-82
A phase II double-blinded, parallel group study to examine the efficacy and safety of BI 425809 once daily with adjunctive Computerized Cognitive Training over 12 wee...
This study is ongoing in the United Kingdom and . It focuses on Schizophrenia.
In United KingdomSchizophreniaOther
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.